An article from the Pittsburgh Post-Gazette referenced an AJMC® supplement regarding the opioid epidemic. The supplement, “Deaths, Dollars, and Diverted Resources: Examining the Heavy Price of the Opioid Epidemic,” includes 9 articles exploring the economic burden of the opioid epidemic on the states, and more. The supplement was also picked up by The Heartland Institute.
The National Pharmaceutical Council’s Monday CER Daily Newsfeed included an AJMC® interview with R. Brett McQueen, PhD, assistant professor, Department of Clinical Pharmacy, Pharmaceutical Outcomes Research, Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado. During the interview, McQueen discussed the need to account for a myriad of criteria when determining cost effectiveness.
Thursday’s CER Daily Newsfeed included AJMC®’s interview with Jeroen Jansen, PhD, lead scientific advisor, Open-Source Value Project, Innovation and Value Initiative, in which he discussed challenges with today’s approaches to value assessment. The newsfeed also included the article “Ibrutinib—Rituximab Improves Survival Compared With Current Treatment for Chronic Lymphocytic Leukemia,” which reported on study findings showing the combination of ibrutinib and rituximab keeps patients with a common form of leukemia alive and disease free longer than the current treatment regimen.